NFKB1 and melanoma: Suppression of MEK/ERK pathway enhances CDDP resistance in human cervical carcinoma cells through activation of NF-κB (nuclear factor κB) pathway [28], whereas Sinnberg et al. [24] reported that inhibition of MEK/ERK pathway has no effect on CDDP cytotoxicity in melanoma cells.